The US Food and Drug Administration has granted tentative approval for Teva Pharmaceutical Industries’s ANDA for Alendronate Sodium Tablets, 5 milograms (mg), 10 mg, 35 mg, 40 mg and 70 mg.

Alendronate sodium is a bisphosphonate used to treat Paget disease of bone (PDB). The approved dosage of 40 mg/day for 6 months is generally well tolerated, but esophageal irritation can occur if the ...

Sun Pharma announced a recall of Alendronate Sodium Tablets 70mg, the generic version of Fosamax. Sun Pharma announced a recall of Alendronate Sodium Tablets 70mg, the generic version of Merck‘s ...

NORTH WALES, Pa. Teva has announced the introduction and availability of alendronate sodium tablets. This is the generic version of the osteoporosis drug Fosamax by Merck. The drug will be available ...

BANGALORE, Sept 12 (Reuters) - India's Sun Pharmaceutical Industries said it has received approval from the U.S. Food and Drug Administration to market alendronate sodium tablets, the generic version ...

Women who have ever used alendronate sodium may be at an increased risk of incident atrial fibrillation, according to recent data published in the Archives of Internal Medicine. Researchers from ...

An 84-year-old woman presented with a one-year history of intermittent chest pain and progressive difficulty swallowing while eating solid food. She had no history of gastrointestinal problems. She ...